PMDA drug package insert
カルバゾクロムスルホン酸ナトリウム静注液25mg「日医工」
PMDA Prescription drug · 日医工株式会社 · package insert Sep 21, 2023
Key facts
| Brand names | カルバゾクロムスルホン酸ナトリウム静注液25mg「日医工」, カルバゾクロムスルホン酸ナトリウム静注液50mg「日医工」, カルバゾクロムスルホン酸ナトリウム静注液100mg「日医工」 |
|---|---|
| Nonproprietary names | カルバゾクロムスルホン酸ナトリウム水和物 |
| Companies | 製造販売元／日医工株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 血管強化・止血剤 |
| Therapeutic category codes | 873321 |
| YJ codes | 3321401A2170, 3321401A3185, 3321401A4246 |
| Approval numbers | 22400AMX00097000, 22400AMX00098000, 22400AMX00099000 |
| Package insert edition | 第1版 |
| Package insert date | Sep 21, 2023 |
| PMDA document key | 530169_3321401A2170_1 |
| PMDA company code | 530169 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: